BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34821009)

  • 1. LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.
    Dong X; Chen X; Lu D; Diao D; Liu X; Mai S; Feng S; Xiong G
    Mol Oncol; 2022 Feb; 16(3):795-812. PubMed ID: 34821009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis.
    Wu C; Wang Z; Tian X; Wang J; Zhang Y; Wu B
    Bioengineered; 2021 Dec; 12(1):3772-3786. PubMed ID: 34281459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
    Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
    BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIR205HG accelerates cell proliferation, migration and invasion in hepatoblastoma through the activation of MAPK signaling pathway and PI3K/AKT signaling pathway.
    Zhang W; Liang F; Li Q; Sun H; Li F; Jiao Z; Lei J
    Biol Direct; 2022 Jan; 17(1):2. PubMed ID: 34996511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA linc00460 sponges miR-1224-5p to promote esophageal cancer metastatic potential and epithelial-mesenchymal transition.
    Cui Y; Zhang C; Lian H; Xie L; Xue J; Yin N; Guan F
    Pathol Res Pract; 2020 Jul; 216(7):153026. PubMed ID: 32534700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis.
    Xu J; Liu X; Liu X; Zhi Y
    Bioengineered; 2021 Dec; 12(1):6687-6702. PubMed ID: 34516362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer.
    Yin L; Zhang Y; Zheng L
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.
    Li Y; Wang H; Huang H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):78-85. PubMed ID: 31023531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
    Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
    Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
    Liu Y; Wang S; Wei S; Qiu X; Mei Y; Yan L
    PLoS One; 2024; 19(1):e0290986. PubMed ID: 38252669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.
    Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK).
    Wang B; Zhang L; Li J; Hua P; Zhang Y
    Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIR205 host gene (MIR205HG) drives osteosarcoma metastasis via regulating the microRNA 2114-3p (miR-2114-3p)/twist family bHLH transcription factor 2 (TWIST2) axis.
    Wang X; Yu X; Long X; Pu Q
    Bioengineered; 2021 Dec; 12(1):1576-1586. PubMed ID: 33949284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
    Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
    Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
    Zhang C; Lian H; Xie L; Yin N; Cui Y
    Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.
    Xue ST; Zheng B; Cao SQ; Ding JC; Hu GS; Liu W; Chen C
    Mol Cancer; 2022 Mar; 21(1):69. PubMed ID: 35255921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.